Symons M - Search Results

1

Abrams M, Reichman N, Khatri D, Patel NV, D'Amico RS, Wong T, Fralin S, Li M, Symons M, Langer D, Filippi CG, Boockvar JA. Abrams M, et al. Among authors: symons m. Clin Neurol Neurosurg. 2020 Aug;195:106075. doi: 10.1016/j.clineuro.2020.106075. Epub 2020 Jul 7. Clin Neurol Neurosurg. 2020. PMID: 32653731 Review.

2

Neuro-oncology biotech industry progress report.

Chakraborty S, Bodhinayake I, Chiluwal A, Langer DJ, Ruggieri R, Symons M, Boockvar JA. Chakraborty S, et al. Among authors: symons m. J Neurooncol. 2016 May;128(1):175-182. doi: 10.1007/s11060-016-2087-z. Epub 2016 Feb 20. J Neurooncol. 2016. PMID: 26897014 Review.

3

Colony Stimulating Factor-1 Receptor Inhibitors-A 4 for 1 Deal in the Desire to Improve Glioma Radiotherapy.

Skeie B, Ruggieri R, Boockvar JA, Symons M. Skeie B, et al. Among authors: symons m. Neurosurgery. 2017 Sep 1;81(3):N27-N28. doi: 10.1093/neuros/nyx389. Neurosurgery. 2017. PMID: 28859456 No abstract available.

4

Repurposing mebendazole for the treatment of medulloblastoma.

Bodhinayake I, Symons M, Boockvar JA. Bodhinayake I, et al. Among authors: symons m. Neurosurgery. 2015 Feb;76(2):N15-6. doi: 10.1227/01.neu.0000460594.93803.cb. Neurosurgery. 2015. PMID: 25594199 No abstract available.

5

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors.

De Witt M, Gamble A, Hanson D, Markowitz D, Powell C, Al Dimassi S, Atlas M, Boockvar J, Ruggieri R, Symons M. De Witt M, et al. Among authors: symons m. Mol Med. 2017 Apr;23:50-56. doi: 10.2119/molmed.2017.00011. Epub 2017 Apr 5. Mol Med. 2017. PMID: 28386621 Free PMC article.

6

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma.

Khan MB, Ruggieri R, Jamil E, Tran NL, Gonzalez C, Mugridge N, Gao S, MacDiarmid J, Brahmbhatt H, Sarkaria JN, Boockvar J, Symons M. Khan MB, et al. Among authors: symons m. Mol Med. 2021 Mar 25;27(1):28. doi: 10.1186/s10020-021-00293-4. Mol Med. 2021. PMID: 33765907 Free PMC article.

7

Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma.

Mukherjee S, Baidoo J, Fried A, Atwi D, Dolai S, Boockvar J, Symons M, Ruggieri R, Raja K, Banerjee P. Mukherjee S, et al. Among authors: symons m. Int J Cancer. 2016 Dec 15;139(12):2838-2849. doi: 10.1002/ijc.30398. Epub 2016 Sep 24. Int J Cancer. 2016. PMID: 27543754 Free article.

8

Signaling Determinants of Glioma Cell Invasion.

Kwiatkowska A, Symons M. Kwiatkowska A, et al. Among authors: symons m. Adv Exp Med Biol. 2020;1202:129-149. doi: 10.1007/978-3-030-30651-9_7. Adv Exp Med Biol. 2020. PMID: 32034712 Review.

9

Signaling determinants of glioma cell invasion.

Kwiatkowska A, Symons M. Kwiatkowska A, et al. Among authors: symons m. Adv Exp Med Biol. 2013;986:121-41. doi: 10.1007/978-94-007-4719-7_7. Adv Exp Med Biol. 2013. PMID: 22879067 Review.

10

Role of Rac1-regulated signaling in medulloblastoma invasion. Laboratory investigation.

Zavarella S, Nakada M, Belverud S, Coniglio SJ, Chan A, Mittler MA, Schneider SJ, Symons M. Zavarella S, et al. Among authors: symons m. J Neurosurg Pediatr. 2009 Aug;4(2):97-104. doi: 10.3171/2009.4.PEDS08322. J Neurosurg Pediatr. 2009. PMID: 19645540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page